Issued Patents All Time
Showing 1–25 of 40 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12070500 | Use of semaphorin-4D antibodies in combination with an immune modulating therapy to inhibit tumor growth and metastasis | Elizabeth E. Evans, Ernest S. Smith | 2024-08-27 |
| 12006365 | Human anti-semaphorin 4D antibody | Ernest S. Smith, Angelica A. Cornelison, Maria G. M. Scrivens, Mark Paris | 2024-06-11 |
| 11597765 | Use of semaphorin-4D binding molecules for the treatment of Rett syndrome | Yilin Mao, Wendy Gold, Elizabeth E. Evans | 2023-03-07 |
| 11572408 | Treatment of cancer with a semaphorin-4D antibody in combination with an epigenetic modulating agent | Elizabeth E. Evans, Ernest S. Smith | 2023-02-07 |
| 11534488 | Use of semaphorin-4D binding molecules for modulation of blood brain barrier permeability | Ernest S. Smith | 2022-12-27 |
| 11427634 | Human anti-semaphorin 4D antibody | Ernest S. Smith, Angelica A. Cornelison, Maria G. M. Scrivens, Mark Paris | 2022-08-30 |
| 11078295 | Use of semaphorin-4D inhibitory molecules with an immune modulating therapy to inhibit tumor growth and metastases | Elizabeth E. Evans, Ernest S. Smith | 2021-08-03 |
| 10800853 | Use of semaphorin-4D binding molecules for treating neurodegenerative disorders | Ernest S. Smith, William Bowers, Alan Jonason | 2020-10-13 |
| 10662422 | Method for selecting polynucleotides encoding antigen-specific immunoglobulin subunit | Ernest S. Smith, Tracy Pandina, Leslie A. Balch, Mark Paris, Angelica A. Cornelison +1 more | 2020-05-26 |
| 10526414 | Use of anti-semaphorin-4D antibodies in combination with an immune modulating therapy to inhibit tumor growth and metastases | Elizabeth E. Evans, Ernest S. Smith | 2020-01-07 |
| 10494440 | Use of semaphorin-4D binding molecules to promote neurogenesis following stroke | Ernest S. Smith | 2019-12-03 |
| 10385136 | Use of semaphorin-4D binding molecules for treating neurodegenerative disorders | Ernest S. Smith, William Bowers, Alan Jonason | 2019-08-20 |
| 10111950 | Modified glycolipids and methods of making and using the same | Steven A. Porcelli | 2018-10-30 |
| 9890213 | Methods for the treatment of B cell-mediated inflammatory diseases | Ernest S. Smith | 2018-02-13 |
| 9828435 | Use of antibodies or antigen-binding fragments thereof that specifically bind semaphorin-4D to increase tumor infiltrating leukocyte frequency | Elizabeth E. Evans, Ernest S. Smith | 2017-11-28 |
| 9809654 | Targeted CD1d molecules | Bruno Robert, Alena Donda, Valerie Cesson, Jean-Pierre Mach | 2017-11-07 |
| 9790271 | Methods for increasing immunoglobulin A levels | Masaru Yoshida, Koji Yamamoto, Ernest S. Smith | 2017-10-17 |
| 9708601 | Fusion proteins to facilitate selection of cells infected with specific immunoglobulin gene recombinant vaccinia virus | Ernest S. Smith, Tracy Pandina, Leslie A. Croy, Mark Paris, Angelica Moksa +1 more | 2017-07-18 |
| 9701958 | Method for selecting polynucleotides encoding antigen-specific immunoglobulin subunits | Ernest S. Smith, Tracy Pandina, Leslie A. Croy, Mark Paris, Angelica Moksa +1 more | 2017-07-11 |
| 9598495 | Use of semaphorin-4D binding molecules for treating neurodegenerative disorders | Ernest S. Smith, William Bowers, Alan Jonason | 2017-03-21 |
| 9512224 | Use of semaphorin-4D binding molecules for treatment of atherosclerosis | — | 2016-12-06 |
| 9371352 | Modified glycolipids and methods of making and using the same | Steven A. Porcelli | 2016-06-21 |
| 9249227 | Use of semaphorin-4D binding molecules for treating neurodegenerative disorders | Ernest S. Smith, William Bowers, Alan Jonason | 2016-02-02 |
| 9243068 | Combination of SEMA-4D inhibitors and immunomodulators to inhibit tumors and metastases | Elizabeth E. Evans, Ernest S. Smith | 2016-01-26 |
| 9090709 | Anti-SEMA4D antibodies and epitopes | Terrence Lee Fisher, Ernest S. Smith | 2015-07-28 |